Ontrak (NASDAQ:OTRK – Get Free Report) and Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation.
Profitability
This table compares Ontrak and Fresenius SE & Co.’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ontrak | -274.20% | -269.88% | -128.35% |
| Fresenius SE & Co. | 5.09% | 9.33% | 4.32% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Ontrak and Fresenius SE & Co., as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ontrak | 0 | 0 | 1 | 0 | 3.00 |
| Fresenius SE & Co. | 0 | 0 | 2 | 1 | 3.33 |
Risk & Volatility
Ontrak has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500. Comparatively, Fresenius SE & Co. has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500.
Institutional and Insider Ownership
13.0% of Ontrak shares are held by institutional investors. 1.9% of Ontrak shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Ontrak and Fresenius SE & Co.”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ontrak | $10.85 million | 0.14 | -$25.49 million | ($15.81) | -0.02 |
| Fresenius SE & Co. | $23.63 billion | N/A | $509.67 million | $0.53 | 24.02 |
Fresenius SE & Co. has higher revenue and earnings than Ontrak. Ontrak is trading at a lower price-to-earnings ratio than Fresenius SE & Co., indicating that it is currently the more affordable of the two stocks.
Summary
Fresenius SE & Co. beats Ontrak on 10 of the 14 factors compared between the two stocks.
About Ontrak
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.
About Fresenius SE & Co.
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Receive News & Ratings for Ontrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ontrak and related companies with MarketBeat.com's FREE daily email newsletter.
